AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 211 min read$ALGN

Piper Sandler maintains Overweight rating on Align Technology, $205 price target

Piper Sandler kept its Overweight rating on Align Technology with a $205 price target, implying a 36.2% upside from the Oct 20 close. The firm cited Align's 90% market share in clear aligners and a 3.4% year-over-year increase in total exams as reasons for its rating.

Original reporting
tradingview.com
Published Oct 21, 2026, 2:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 2:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Piper Sandler maintains Overweight rating on Align Technology, $205 price target — source image
Source · tradingview.com
Decision brief

The 30-second read

$ALGNBullishMed
01

Why it matters

Analyst maintains Overweight and raises target, suggesting continued confidence in market leadership.

02

Market read

The new target could prompt short‑term buying pressure in ALGN shares.

03

What to watch

Potential slowdown in volume growth and competitive pressure from emerging low‑cost aligner makers.

Relevance 6/10Novelty 5/10Timing: today

Background

Align Technology dominates the clear aligner market with Invisalign, holding over 90% share and treating 14 million patients.

Company-level read

Ticker impact

$ALGNBullishMedium confidence
Context

Piper Sandler maintained an Overweight rating on Align Technology and set a new price target of $205, implying a 36% upside from the recent close.

Expected impact

potential upside as investors price in the higher target.

Evidence & confidence

The rating and target are fresh analyst guidance that could attract buying interest.

Market effects

Sector

reinforces positive outlook for the clear‑aligner segment and orthodontic devices.

Regional

U.S. dental and orthodontic market may see modest buying pressure.

Global

limited to companies with similar orthodontic product lines.

Counterpoint

What could challenge this read

The rating is unchanged; the price target may already be priced in, limiting upside.

Key entities

  • Analyst Firm
    Piper Sandler

    Equity research house issuing the rating and target.

  • Company
    Align Technology

    Provider of Invisalign clear aligners.

Read at source← All news

Related articles

OCT 25
$ALGNMed

Invisalign’s Moment of Truth: Will International Growth Save ALGN on Oct 28?

Align Technology (ALGN) reports Q3 earnings on Oct 28. Q2 saw record aligner shipments (+7.4% YoY) but scanner revenue fell 10.8%. International growth offset North American softness. Analysts expect Q3 revenue of $1.004B (+0.9% YoY) and EPS of $2.77 (+6.0% YoY). Management anticipates ASP declines due to pricing pressure and geographic mix. Scanner revenue is guided down 6-8% for 2026. Shares are down 1.05% YTD.

247wallst.com2 min
OCT 17
$ALGNMed

Align Technology Wins UPC Patent Case Against Angelalign

Align Technology (ALGN) won a patent case against Angelalign in the Unified Patent Court, which ruled that Angelalign's Torque Ridges feature infringes Align's European patent. The court ordered Angelalign to recall and destroy infringing products, awarded damages, and granted additional relief. The decision impacts multiple European countries and is subject to appeal. ALGN shares closed at $147.31, down 1.36%.

rttnews.com2 min
OCT 17
$ALGNHigh

A European court ordered Angelalign to stop offering some teeth-straightening trays in parts of Europe. The decision is subject to appeal.

A European court ruled that Angelalign's Torque Ridges feature infringes Align Technology's patent, ordering Angelalign to stop offering the product in parts of Europe. Align (ALGN) welcomed the decision, which includes damages and an injunction. Angelalign (6699.HK) can appeal. The ruling follows prior patent disputes between the companies.

stocktitan.net2 min
OCT 9
$ALGNHigh

Stifel cuts Align Technology stock price target on weak demand

Stifel reduced Align Technology's (ALGN) price target to $175 from $210, citing weak U.S. Invisalign demand. Shares are down 10% YTD and 19% over six months. Analysts note soft conversion and volume trends, with earnings estimates being revised downward. ALGN reported Q2 2026 earnings of $2.64 per share on $1.06B revenue, slightly beating expectations, but guidance indicated near-term pressure. Evercore ISI downgraded ALGN to In Line with a $155 target.

investing.com2 min